Figure 3 | Scientific Reports

Figure 3

From: One-year visual and anatomical outcomes of intravitreal faricimab injection for neovascular age-related macular degeneration after prior brolucizumab treatment

Figure 3

An 86-year-old woman who had received 8 intravitreal brolucizumab injections and 30 intravitreal aflibercept before the initial intravitreal faricimab (IVF) injection. (a) Optical coherence tomography (OCT) shows a thick choroid and dilated large choroidal vessels underlying an attenuated choriocapillaris with no exudative change at the initial IVF injection. The injection interval was 15 weeks before the last intravitreal brolucizumab. (b) OCT shows no exudative change or dilated choroidal vessels a year after initial IVF.

Back to article page